Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer
T Aydillo, AS Gonzalez-Reiche, S Aslam… - New England journal …, 2020 - Mass Medical Soc
New England journal of medicine, 2020•Mass Medical Soc
Shedding of SARS-CoV-2 after Immunosuppression The prolonged contagious period after
viral infection in immunocompromised patients may affect how long precautions will be
necessary to reduce further transmission. Replication-competent SARS-CoV-2 was detected
for up to 61 days in patients who were immunocompromised by treatment for cancer.
viral infection in immunocompromised patients may affect how long precautions will be
necessary to reduce further transmission. Replication-competent SARS-CoV-2 was detected
for up to 61 days in patients who were immunocompromised by treatment for cancer.
Shedding of SARS-CoV-2 after Immunosuppression
The prolonged contagious period after viral infection in immunocompromised patients may affect how long precautions will be necessary to reduce further transmission. Replication-competent SARS-CoV-2 was detected for up to 61 days in patients who were immunocompromised by treatment for cancer.
The New England Journal Of Medicine